Accession Number: | 0001225208-21-002568 |
Date: | 2021-02-16 |
Issuer: | EDWARDS LIFESCIENCES CORP (EW) |
Original Submission Date: |
SZYMAN CATHERINE M.
ONE EDWARDS WAY
IRVINE, CA 92614
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-02-16 | M | 3,389 | a | $22.29 | 30,135 | direct | ||
COMMON STOCK | 2021-02-16 | S | 3,389 | d | $88.20 | 26,746 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO ACQUIRE) | 22.2867 | 2021-02-16 | deemed execution date | M | 3,389 (d) | 2016-02-19 | 2022-02-18 | common stock 3,389 | $22.29 | 13,577 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 24, 2020. |